ReviewInternational journal of molecular medicine2026
Primary cilia dysfunction: A critical driver of metabolic diseases (Review).
Review in International journal of molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cilia dysfunction has been identified as a crucial but frequently overlooked factor in the pathogenesis of metabolic diseases, including obesity and diabetes. This review examines the multifaceted roles of primary cilia in various metabolic tissues, framed by a central bidirectional model. This model posits a self‑reinforcing cycle where disruptions in ciliary function contribute to dysregulated appetite control, impaired insulin secretion and increased fat storage. Conversely, the hallmarks of metabolic disease, including chronic inflammation, lipotoxicity and hyperglycemia, contribute to the impairment of ciliary structure and function, thereby accelerating disease progression. The review underscores this reciprocal causality and proposes that therapeutic strategies targeting ciliary function could break this vicious cycle. Emerging treatments aim to restore ciliary function and thereby mitigate the progression of metabolic diseases. By elucidating the mechanisms of this bidirectional relationship, this review aims to pave the way for innovative strategies that optimize clinical outcomes and improve patient quality of life.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.